| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |